Clinical Trial

Holter of Movement in Patients with Multiple Sclerosis in Uncontrolled Environment.

Study acronym: ActiMS
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 12, 2025 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be included on a voluntary basis. The investigators plan to include a group of approximately 80 patients with MS, fulfilling the McDonald's 2017 criteria, of whom 40 of them show a progressive course according to the Lublin classification. The investigators have planned two visits (at baseline and 1 year later). On both visits, participants will perform few tests (timed 25-Foot Walk (T25-FW), 9-Hole Peg Test (9-HPG), 6-minutes walk test (6MWT), Berg balance scale) and will answer to some questionaires (Godin Leisure Time Exercice Questionnaire, multiple sclerosis walking scale, modified fatigue impact scale, Hospital Anxiety and Depression Scale) After each visit, participants will wear Actimyo for three months in daily living.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-05-11; most recent amendment 2025-02-10.
Status change: Recruiting → Active, Not Recruiting 2023-10-06
Trial Details
NCT Number NCT04882891
Lead Sponsor Centre Hospitalier Universitaire de Liege
Collaborators: SYSNAV, Centre Hospitalier Régional de la Citadelle
Conditions Multiple Sclerosis
Enrollment 80 participants
Start Date 2021-03-09
Primary Completion 2026-02-15 (estimated)
Study Completion 2026-02-15 (estimated)
Updated on ClinicalTrials.gov 2025-02-12